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Introduction
For enteric pathogenic bacteria, physiological changes
are essential to maintain viability and pathogenicity by
adapting to various host environments, including nutrient
fluctuation and oxygen limitation [28, 36]. Vibrio cholerae,
the causative agent of the pandemic disease cholera, is a
facultative anaerobic pathogenic bacterium [7, 16]. Although
the pathogenesis caused by this deadly bacterium takes
place in the intestine, which is commonly thought to be an
anaerobic environment, the mechanism of virulence gene
expression under anaerobic conditions is not fully
understood. 
The ability of V. cholerae to colonize and cause disease in
the host requires the production of virulence factors during
infection, including cholera toxin (CT) and toxin coregulated
pilus (TCP). CT provokes watery diarrhea by the generation
of ion transport imbalance across the intestinal epithelium,
and the type IV TCP contributes to intestinal colonization
[19, 41]. Expression of both genes is regulated by a variety
of factors that are able to respond to environmental signals.
An AraC-type master transcription factor, ToxT, which is
regulated by the membrane-associated proteins ToxR and
TcpP/TcpH, directly activates transcription of the ctxAB
genes (encoding CT) and the genes for TCP biogenensis [4,
5, 9, 24, 25, 38]. In addition, the activation of tcpP/H (genes
encoding TcpP and TcpH, respectively) expression requires
two transcriptional activators, AphA and AphB [3, 17].
However, regulation of the ToxT regulon that mediates CT
production was defined using strains grown in AKI media,
an in vitro culture condition known to be permissive for CT
production [15]. Several studies demonstrated that AphB,
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The causative agent of pandemic cholera, Vibrio cholerae, infects the anaerobic environment of
the human intestine. Production of cholera toxin (CT), a major virulence factor of V. cholerae, is
highly induced during anaerobic respiration with trimethylamine N-oxide (TMAO) as an
alternative electron acceptor. However, the molecular mechanism of TMAO-stimulated CT
production is not fully understood. Herein, we reveal that CT production during anaerobic
TMAO respiration is affected by glucose fermentation. When the seventh pandemic V. cholerae
O1 strain N16961 was grown with TMAO and additional glucose, CT production was
markedly reduced. Furthermore, an N16961 ∆crp mutant, devoid of cyclic AMP receptor
protein (CRP), was defective in CT production during growth by anaerobic TMAO respiration,
further suggesting a role of glucose metabolism in regulating TMAO-mediated CT production.
TMAO reductase activity was noticeably decreased when grown together with glucose or by
mutation of the crp gene. A CRP binding region was identified in the promoter region of the
torD gene, which encodes a structural subunit of the TMAO reductase. Gel shift assays further
confirmed the binding of purified CRP to the torD promoter sequence. Together, our results
suggest that the bacterial ability to respire using TMAO is controlled by CRP, whose activity is
dependent on glucose availability. Our results reveal a novel mechanism for the regulation of
major virulence factor production by V. cholerae under anaerobic growth conditions. 
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the key transcriptional activator of the tcpP gene, activates
virulence gene expression through anaerobiosis-induced
dimerization and activity [18, 22]. In addition, a previous
study showed that the production of three colonization
factors (TcpC, TcpQ, and TcpS) and accessory colonization
factor A (AcfA) is induced under anaerobiosis [23].
Together, these results suggest that oxygen limitation may
be the key to regulating pathogenic processes of V. cholerae
during host intestinal infection. 
Recently, we reported that CT production is substantially
enhanced by anaerobic respiration using trimethylamine
N-oxide (TMAO) as an alternative electron acceptor, and
it is mediated by the accumulation of guanosine
pentatetraphosphate (termed (p)ppGpp), also known as a
bacterial stress alarmone [21, 34]. Meanwhile, our recent
report demonstrated that (p)ppGpp confers a growth and
survival advantage through acetoin fermentation, a known
V. cholerae strategy to avoid fatal acidification of the growth
environment in glucose-enriched environments [33, 43]. Up
to 70-80% of cholera patients recover by treatment with
the continuous administration of oral rehydration solution
(ORS). Because a large amount of glucose is present in
ORS, it is speculated that continuous administration of
ORS may create glucose-enriched microenvironments in
the human intestine [6, 10, 35, 37]. Subsequently, the growth
and virulence of V. cholerae may be influenced by glucose
metabolism under anaerobic conditions. Therefore, we
predicted that the (p)ppGpp-mediated CT production and
growth advantage are diminished by glucose in the human
intestine. Until now, the relationship between glucose
metabolism and virulence regulation under anaerobic
conditions has not yet been explored. 
In this study, we revealed that the utilization of TMAO in
anaerobic respiration, which stimulates CT production, is
repressed by glucose fermentation. This work is an
extension of our previous study and describes a regulation
mechanism for the production of CT under anaerobic
conditions. This report provides evidence that the production
of CT, an important virulence factor, is critically controlled
by anaerobiosis-induced glucose metabolism.
Materials and Methods
Bacterial Strains and Growth Conditions
All bacterial strains and plasmids used in this study are listed in
Table 1. Bacterial cultures were grown at 37°C in lysogeny broth
medium (LB; 1% tryptone, 0.5% yeast extract, and 1% NaCl per
liter), and antibiotics were used in the following concentrations;
ampicillin, 100 µg/ml; streptomycin, 200 µg/ml; and kanamycin,
50 µg/ml. To support anaerobic growth, 50 mM TMAO (Sigma
Aldrich Co., St. Louis, MO, USA) was added to the medium (termed
LBT). The effect of glucose was assessed using cells grown in LB or
LBT containing 1% glucose (termed LBG and LBTG, respectively).
An overnight culture of bacterial cells was subcultured at a 1/100
dilution in fresh medium and grown at 37°C in an anaerobic
chamber. Bacterial growth was monitored spectrophotometrically
by measuring the optimal density at 600 nm, and the pH of the
culture media was monitored using a pH meter.
Transposon Mutagenesis and Dot Blot Assay
Construction of a transposon insertion mutant library was
performed following previously described procedures [21]. N16961-
derived mutants were grown in 96-well plates anaerobically in
LBT. After overnight growth, culture supernatants from each well
Table 1. Bacterial strains and plasmids used in this study.
Strains or plasmids Relevant characteristics Ref. or source
V. cholerae strains
N16961 Wild type, O1 serogroup, El Tor biotype Lab. collection
C6706 Wild type, O1 serogroup, El Tor biotype Lab. collection
O395 Wild type, O1 serogroup, classical biotype Lab. collection
crp::Tn N16961, Tn inserted in coding region of VC2614 gene This study
∆crp N16961, crp gene deleted This study
E. coli strains
SM10/λpir Kmr
 
thi-1 thr leu tonA lacY supE recA::RP4–2-Tc::Mu pir+, for conjugal transfer Lab. collection
BW20767 Km::Tn7 leu-63::IS10 recA1 creC510 hsdR17 endA1 zbf-5 uidA(∆Mlu1)::pir+thi Lab. collection
BL21b supE44 DlacU169 (f80lacZ DM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Lab. collection
Plasmids
pCVD442 sacB suicide vector from plasmid pUM24 [21]
pBTK30 Transposon insertion vector, Gmr [26]
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were spotted on a nitrocellulose membrane (Bio-Rad Laboratories
Inc., Hercules, CA, USA) using a 96-well pin replicator. Membranes
were then blocked and probed with a rabbit polyclonal antibody
against CT subunit B (Abcam Inc., Cambridge, UK) following a
standard western blot protocol. To determine the location of the
transposon insertion site, arbitrary PCR was performed with the
primers listed in Table 2.
Construction of Mutant Strain
The crp in-frame deletion mutants were created by allele
replacement as previously described [21]. The 500 base pair
flanking sequences located at both ends to introduce mutation
were amplified by PCR with the primers listed in Table 2.
CT ELISA Assays
CT production was measured using V. cholerae culture
supernatants by GM1-enzyme-linked immunosorbent assays (GM1-
ELISA) as described previously [39]. Purified CT subunit B (List
Biological Laboratories Inc., Campbell, CA, USA) was used to
provide a standard curve and phosphate-buffered saline (PBS) was
used as a negative control. Rabbit polyclonal anti-CT subunit B
(Abcam Inc.) and anti-rabbit immunoglobulin G conjugated with
horseradish peroxidase (Santa-Cruz Biotechnology Inc., Dallas,
TX, USA) were used for detection.
Microarray Analysis
Differential gene expression analysis was performed using
Roche NimbleGen Vcho expression arrays (4 × 72K), consisting of
72,000 probes representing 3,835 ORFs from the V. cholerae N16961
strain. The V. cholerae N16961 strain was anaerobically grown in
LB, LBT, or LBTG for 6 h. Total bacterial RNA was isolated from
each of the three independent cultures and RNA was extracted
using TRIzol reagent (Invitrogen, Burlington, ON, Canada)
following the manufacturer’s instructions. Extracted RNA was
further purified using an RNeasy kit (Qiagen). Purified RNA
samples were then pooled together and submitted to GenoCheck
Inc. (Ansan, South Korea) for subsequent experimentation. Slides
were scanned using the Axon 4000B microarray scanner system,
and images were processed using NimbleScan 2.4 software (Roche
Technologies). For differentially expressed gene selection, GeneSpring
(ver. 11.5.1) was used. 
Purification of CRP
For recombinant protein production, the CRP-encoding gene
from N16961 was PCR-amplified and positionally cloned into
pET21b. The primer set used for cloning is listed in Table 2. The
resulting plasmid was then transformed into E. coli BL21(DE3).
Then 1 mM IPTG was used to induce overexpression, and
recombinant hexahistidine-tagged (6His) proteins were purified
using Ni-NTA agarose (Qiagen). Protein purity was >95%, as
determined densitometrically after separation by SDS-PAGE and
staining with Coomassie blue. The Bradford method was used to
determine the concentration of 6His-CRP with comparison against
a standard curve generated with bovine serum albumin. Purified
proteins were stored at -20oC to prevent degradation.
Electrophoretic Mobility Shift Assay
Complimentary oligonucleotides (40 bp) that contain the region
of putative CRP binding sequences were synthesized with a 5’-
biotinylated modification (Macrogen Inc., Seoul, Korea). Mixed
complementary oligonucleotides (1:1 molar ratio) were incubated
at 95°C for 5 min followed by a gradual reduction in heat until the
Table 2. Primers used in this study.
Gene name Direction Primer sequence (5’-3’)a Restriction sites
Cloning
crp (His-tag) Forward ACCTTCATATGGTTCTAGGTAAACCTCAAACC NdeI
Reverse TAGAGCTCGAGGCGAGTGCCGTAAACCACGATG ZhoI
crp left (in-frame deletion) Forward CTCTAGAGCTCGCGTGTTCCTACGGTCGATA SacI
crp left (in-frame deletion) Reverse TGGAAGGATCCTGGATCGGTTTGAGGTTTACC BamHI
crp right (in-frame deletion) Forward CTCTAGGATCCGTGGTTTACGGCACTCGCTA BamHI
crp right (in-frame deletion) Reverse TGGAAGAGCTCCAAGCATTAGCCAGTGAGGC SacI
Arbitrary PCR
BTK30-Tnp1, 1 round Forward CACCGCTGCGTTCGGTCAAG
RP-1, 1 round Reverse CTTACCAGGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
RP-2, 1 round Reverse CTTACCAGGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC
BTK30-Tnp2, 2 rounds Forward CGAACCGAACAGGCCTTATGTTCAATTC
RP-3, 2 rounds Reverse CTTACCAGGCCACGCGTCGACTAGTAC
BTK30-Tnp3 Sequencing TGGTGCTGACCCCGGATGAAG
aRestriction enzyme recognition sequences are underlined.
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oligonucleotides reached room temperature. Purified 6His-CRP
(300 nM) was incubated with 1 nM biotin-labeled DNA and 1 µM
cAMP in binding buffer (10 mM Tris-HCl (pH 7.5), 100 mM NaCl,
0.5 mM EDTA, 1 mM DTT, 5% (v/v) glycerol, and 50 ng/µl
poly(dI·dC)) for 15 min at 20°C. For the competitor DNA, a 10-,
50-, or 100-fold molar excess of unlabeled target DNA was added
to each reaction mixture, respectively, with the extract before the
labeled DNA target was added. The mixtures were size fractionated
on a non-denaturing 5% polyacrylamide gel, followed by drying
and transfer onto nitrocellulose membranes. Signals were detected
by streptavidin-horseradish peroxidase chemiluminescence for
biotin-labeled probes according to the manufacturer’s instructions
(Pierce). The images were visualized using the ChemiDoc XRS
system with image software (Bio-Rad).
TMAO Reductase Activity Assay
V. cholerae strain N16961 and the crp mutant were grown
anaerobically in LB, LBG, LBT, or LBTG for 6 h. To analyze TMAO
reductase activity in different cellular fractions, the periplasmic
and cytoplasmic fractions were separated by polymyxin B
treatment. Cell pellets were resuspended with PBS containing
2,000 units of polymyxin B and incubated for 15 min at 4°C. After
incubation, the reaction mixtures were centrifuged at 12,000 rpm
for 10 min and the supernatants were collected for periplasmic
fractions. The cell pellets were then resuspended in PBS and
sonicated to produce cytoplasmic fractions. Equal amounts of
proteins present in each fraction were resolved on a 9% non-
denaturing polyacrylamide gel, and a native gel-based enzyme
assay was performed as previously described [44].
Confocal Microscopy
Differential interference contrast (DIC) and green fluorescent
images were acquired using a confocal laser scanning microscope
(FV-1000; Olympus Optical Co. Ltd., Japan) and its operating
software, FV10-ASW (ver. 02.01). Detailed procedures are described
elsewhere [20]. For reactive oxygen species (ROS) detection,
bacterial cells were grown anaerobically for 4 h with 50 mM TMAO
or 1% glucose. Aliquots of each culture were removed and stained
with 10 µM DCF-DA (2’,7’-dichlorofluorescein diacetate; Sigma)
for 30 min. To capture the green fluorescence, samples were
scanned at 488 nm and emission was detected through a 520 nm
band filter. The DIC and green fluorescence images were collected
simultaneously.
Statistical Analysis
Data are expressed as the mean ± SD. An unpaired Student’s
t test was used to analyze the data. A p-value of <0.05 was
considered statistically significant. All experiments were repeated
for reproducibility.
Results
Identification of a V. cholerae Mutant That Lost the
Ability to Produce CT During Anaerobic TMAO Respiration
Our previous studies showed that V. cholerae O1 serotype
strains produced a high level of CT during anaerobic
TMAO respiration, in a manner dependent on the stringent
response [21, 34]. These results uncovered a novel growth
condition for V. cholerae virulence and provided an insight
into the basis of elevated CT production. To better
understand the mechanistic details, we constructed a
transposon (Tn) insertion mutant library and isolated a
mutant that became defective in CT production under the
same growth condition that permitted robust CT production
in the N16961 parental strain. Over 1,200 mutants were
screened by a dot-blot analysis using an antibody against
CT subunit B. One mutant that harbored a transposon
insertion in the VC2614 gene was validated (Fig. 1). The
VC2614 gene encodes cAMP receptor protein (CRP, also
known as catabolite activator protein), which regulates
genes involved in carbon source metabolism [2, 30]. The
crp::Tn mutant was clearly defective in CT production
when grown anaerobically in the presence of 50 mM
TMAO (Fig. 1). N16961 cells produced a significant level of
CT under the same growth condition. CT production was
not observed in N16961 cells grown in plain LB (Fig. 1).
This result further confirms that CT production occurs
during anaerobic TMAO respiration and suggests that CRP
Fig. 1. CT production was decreased in the crp::Tn mutant
during anaerobic TMAO respiration. 
Wild-type N16961 and the crp::Tn mutant were inoculated in separate
LB and LBT (LB containing 50 mM TMAO) cultures and grown
statically in an anaerobic chamber for 16 h. Culture supernatants were
harvested and the CT level was quantified by ELISA. *p < 0.05 vs. CT
levels produced from wild-type N16961. Three independent experiments
were performed and the mean ± SD represented in the bar graph.
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is closely linked to the mechanism of TMAO-stimulated CT
production.
CT Production Is Repressed by Glucose During TMAO-
Induced Anaerobic Respiration
As a transcriptional activator, CRP functions in conjunction
with cAMP. When bound to cAMP, CRP-mediated
transcriptional regulation occurs more specifically [11], and
in E. coli, intracellular cAMP levels are inversely correlated
with medium glucose concentration [32]. These notions led
us to postulate that the phenotypes observed in the
V. cholerae crp::Tn mutant with respect to CT production
may be similar to those found in the wild-type strain under
glucose-rich conditions. To address this issue, we grew
bacterial strains anaerobically in the presence of both
50 mM TMAO and varying concentrations of glucose. As
shown in Fig. 2A, CT production gradually decreased
when the levels of added glucose increased (black bars). In
the presence of 1% glucose, only a negligible amount of CT
was produced in N16961. Consistently, CT production was
not detectable in the ∆crp mutant (gray bars). CT production
induced upon anaerobic TMAO respiration was also detected
in C6706 (another El Tor biotype) and O395 (a classical O1
serotype strain) (Fig. 2B). When grown with 1% glucose,
CT production was markedly decreased in these two strains
(Fig. 2B), suggesting that the glucose-mediated suppression
of CT production is consistent in related V. cholerae strains.
Expression of Genes Involved in TMAO Respiration
Decreased in the Presence of Glucose in a CRP-
Dependent Manner During Anaerobic Respiration
We performed a microarray analysis to elucidate the
effect of added glucose on genome-wide expression profiles.
When grown with glucose, the expression of genes involved
in the production of functional TMAO reductase was
substantially decreased (Table 3). Expression of these genes
was highly induced in cells grown anaerobically in LBT.
For example, the torA gene encoding a structural component
of the TMAO reductase was actively transcribed when
grown with TMAO. The level of its transcription was
increased by more than 20-fold in N16961 cells grown
anaerobically by TMAO respiration; however, when grown
in LBTG medium, transcription decreased back to the level
found in cells grown in plain LB (Table 3). These results
suggest that the presence of glucose suppresses the ability
of V. cholerae to grow by anaerobic TMAO respiration. To
further address this notion, we measured TMAO reductase
activity in N16961 and its ∆crp mutant. Consistent with
results in Table 3, TMAO reductase activity was substantially
decreased in N16961 cells grown in LBTG compared with
LBT-grown cells (Fig. 3). When grown in LBT, a condition
that activates anaerobic growth by TMAO respiration,
TMAO reductase activity was not induced in the ∆crp
mutant (Fig. 3). These findings further demonstrate that a
lack of CT production in the mutant is tightly associated
Fig. 2. Glucose represses TMAO-stimulated cholera toxin production. 
(A) Effect of the presence of glucose on CT production. N16961 cells were grown anaerobically in LBT for 16 h with 2-fold serially diluted 2%
glucose and culture supernatants were assayed for CT ELISA. *p < 0.05 vs. CT produced in N16961. (B) The levels of CT produced in various strains
grown anaerobically in LBT or LBTG (LBT containing 1% glucose) for 16 h. *p < 0.05 vs. CT levels produced under LBT growth conditions.
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with its defect to activate TMAO reductase.
We then sought to understand how bacterial strains
respond to diverse growth conditions. N16961 appeared to
grow better anaerobically in LBG vs. LB (Fig. 4A). However,
a sharp decrease in medium pH was observed in LBG
(Fig. 4B) and acidification-induced loss of viability was
observed (data not shown). When grown in LBT, the
medium pH increased owing to the accumulation of
trimethylamine (TMA), the product of TMAO reductase
(Fig. 4B). Of note is that N16961 grew most actively in
LBTG (Fig. 4A). Under this condition, medium acidification
was not as severe as observed in LBG (Fig. 4B). Interestingly,
anaerobic growth of the ∆crp mutant in LB was not as
active as its parental strain, N16961 (Fig. 4A). Furthermore,
anaerobic growth of the mutant in LBT was severely
delayed compared with N16961 (Fig. 4A). This is likely
ascribed to reduced TMAO reductase activity incurred by
mutation of the crp gene (Fig. 3). 
cAMP-CRP Complex Binds to the Shared Promoter Between
the Divergently Transcribed torR and torD Genes
Our results suggest that CRP positively regulates the
expression of genes involved in TMAO reductase. It is of
note that the torR and torD gene promoter region contains a
potential CRP recognition sequence (Fig. 5A). To determine
whether CRP binds to this genetic element, we performed
an electromobility shift assay. As shown in Fig. 5B, purified
CRP, in conjunction with cAMP, bound directly to the
Table 3. Microarray analysis of genes affected by glucose during TMAO respiration.
Gene No.
LB
signal value
LBT
signal value
LBTG
signal value
Product name Function
VC1692 351.4164 7,153.128 413.4143 TorA Trimethylamine N-oxide reductase
VC1693 433.8665 9,246.063 517.9152 TorC Cytochrome c-type protein
VC1719 341.936 5,51.0156 312.8968 TorR DNA-binding transcriptional regulator
VC1720 266.2405 4,926.492 304.7419 TorD Chaperone protein
Microarray analysis reveals that the expression of genes involved in TMAO utilization is decreased by glucose during anaerobic respiration.
Fig. 3. TMAO reductase activity decreased by glucose or by
mutation of the crp gene. 
Bacterial strains were grown anaerobically in LB, LBT, LBG, or LBTG
for 6 h. Proteins present in the cytoplasmic (C) and periplasmic (P)
fractions were separated by native gel electrophoresis and stained for
TMAO reductase activity as described in the Materials and Methods.
Fig. 4. Bacterial growth and pH changes of the culture media. 
Various growth-associated parameters of the N16961 (black) and crp deletion mutant (white) strains were measured every 3 h during growth in LB
(diamonds), LBT (squares), LBG (circle), or LBTG (triangle). (A) Aliquots of each culture were withdrawn at the designated times and the OD600
values were plotted for growth curves. (B) The medium pH was measured in aliquots of culture supernatants and was plotted with respect to time.
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promoter. The protein without extraneously added cAMP
failed to bind to the promoter sequence (Fig. 5B, second
lane). Furthermore, this binding was specific since non-
labeled promoter DNA was able to compete for CRP
binding. Together, these data strongly indicate that CRP
positively regulates transcription of torR and torD, two
genes important for the production of functional TMAO
reductase.
Production of Intracellular ROS, Generated During
Anaerobic TMAO Respiration, Is Diminished when Grown
Together with Glucose or by Mutation of the crp Gene
Our previous results suggested that ROS are produced
during anaerobic TMAO respiration and CT production is
likely an outcome of bacterial responses to ROS [21]. Since
our current study revealed a suppressive role of glucose
in CT production, we examined whether ROS-specific
fluorescent signals could be detected in bacterial cells
grown with added glucose. Fig. 6 clearly demonstrates that
DCF-DA signals were detected only in N16961 grown
anaerobically in LBT. ROS-specific signals were not
detectable in N16961 grown with TMAO and glucose
(Fig. 6). In addition, the ∆crp mutant cells, incapable of
producing CT during anaerobic TMAO respiration, did not
produce ROS-specific signals when grown in LBT (Fig. 6).
Together, these results further corroborate that glucose
Fig. 6. The level of intracellular ROS was decreased by glucose or by mutation of the crp gene during anaerobic TMAO respiration. 
Confocal microscope images. Bacterial cells grown anaerobically in LB, LBG, LBT, or LBTG. Upper images in each panel represent merged DIC and
green fluorescent images, whereas lower images represent only green fluorescent images. Bacterial cells grown in each medium for 4 h were
stained with 10 µM DCF-DA for 50 min and processed for confocal microscopic analysis. Images were acquired at 1,000× magnification.
Fig. 5. Gel mobility shift assay of the torD promoter region using 6His-CRP. 
The cAMP-CRP complex interacts with the torD promoter. (A) The sequence of the CRP binding sites at the torD promoter region. (B) A
biotinylated DNA fragment of the torD promoter was incubated with purified 6His-CRP as described in the Materials and Methods. Unlabeled
competitor DNA probes were added to the binding reaction at a 10-, 50-, or 100-fold excess relative to the biotinylated torD DNA probe. Equal
aliquots of the binding reaction mixture were then electrophoresed on non-denaturing 5% acrylamide gels and the position of the torD probe was
visualized by streptavidin-horseradish peroxidase chemiluminescence.
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metabolism created an environment that suppresses TMAO
respiration, ROS generation, and thus CT production. 
Discussion
V. cholerae can grow by carbohydrate fermentation [31].
When grown with glucose, the V. cholerae O1 El Tor biotype
strain can activate the 2,3-butanediol fermentation pathway
to fully catabolize available glucose. Since 2,3-butanediol
is a neutral fermentation end-product, uninterrupted
production of 2,3-butanediol can prevent medium acidification
and therefore maintain cell viability [43]. Under anaerobic
conditions, V. cholerae can also support growth by respiration
using alternative electron acceptors, such as TMAO and
fumarate [21]. We previously demonstrated that CT
production was highly induced in V. cholerae strains grown
by anaerobic TMAO respiration [21]. This finding uncovered
a novel growth condition that leads to robust CT production
and supports the idea that bacterial virulence is tightly
associated with energy metabolism [27]. However, little
attention has been paid to (i) how V. cholerae manages its
anaerobic growth when both growth modes (i.e., fermentation
and respiration) are available, and (ii) how its virulence is
affected under each anaerobic growth condition. 
In this work, we elucidated the effect of glucose metabolism
on CT production, triggered by anaerobic TMAO respiration.
Under anaerobic conditions, N16961 lost viability owing to
medium acidification as a result of glucose fermentation,
suggesting that the 2,3-butanediol fermentation pathway
may not be operational anaerobically (Fig. 4B). When
grown with TMAO, a compound that stimulates anaerobic
respiration, N16961 also lost viability, likely due to the
overproduction of ROS, while CT production was greatly
induced [34]. These two findings suggest that V. cholerae,
although classified as a facultative anaerobe [23], cannot
optimally propagate under anaerobic conditions. In addition,
anaerobic growth in plain LB was not robust (Fig. 4A). We
postulate that such defects in anaerobic growth may account
for the ability of V. cholerae to only cause acute infection in
the anaerobic human intestine, with a short incubation
period of normally less than 7 days [1, 8]. 
Based on our results shown in Fig. 3 and Table 3, TMAO
reductase activity was substantially decreased in N16961
grown with both TMAO and glucose. This result suggests that
stimulation of fermentative growth by glucose suppresses
respiratory growth using TMAO. Ironically, however, bacterial
growth in the presence of both glucose and TMAO was
most active (Fig. 4A), due to a pH neutralization effect by
the production of TMA, which serves as a base. TMA
production mitigated the medium acidification elicited by
the accumulation of organic acids. These findings suggest
that (i) V. cholerae responds quite sensitively to changes in
medium pH, and (ii) the two distinct growth modes (i.e.,
fermentation and respiration) are not cooperative in
supporting anaerobic growth of V. cholerae. Catabolite
repression induced by glucose often occurs to suppress
metabolism of other carbon sources [40]. In E. coli, the
production of glycerol-3-phosphate dehydrogenase, an
enzyme involved in anaerobic electron transfer, was
reported to require cAMP, suggesting that cAMP plays a
role in regulating anaerobic metabolism [42]. Our results
show that intracellular levels of cAMP can positively control
the production of TMAO reductase, a major anaerobic
respiratory enzyme. To our best knowledge, this is the first
demonstration that catabolite repression can occur between
fermentative and respiratory growth in V. cholerae.
The stringent response, a bacterial adaptation response
to nutrient starvation, was shown to be activated during
anaerobic TMAO respiration [34]. This suggests that CT
production in V. cholerae is stimulated when cells encounter
adverse growth conditions. When glucose was added,
anaerobic growth of N16961 was significantly increased
(Fig. 4A), and at the same time, CT production was almost
completely abrogated. These results further suggest that
CT production inversely correlates with the degree of
bacterial growth. It is of note that oral rehydration solution,
a primary therapy for cholera, contains a large amount of
glucose (2% w/v) [29]. ORS treatment results in considerable
water absorption from the intestinal lumen [13, 14] and a
decrease in net stool output is observed in ORS-treated
cholera patients [12]. Since the addition of glucose suppressed
CT production under a growth condition that otherwise
permitted CT production, glucose in ORS may serve as an
agent that inhibits CT production in vivo. 
In conclusion, we identified a novel effect of glucose
metabolism on V. cholerae anaerobic growth and virulence.
Glucose metabolism exerts a wide range of functions in
V. cholerae, as it influences bacterial viability depending on
oxygen availability and virulence. Our results (summarized
in Fig. 7) put a renewed emphasis on understanding
V. cholerae virulence in association with metabolism. CRP,
as a major transcriptional regulator, controls the expression
of many genes, including those involved in carbohydrate
catabolism. Here, two more genes encoding TorR and TorD
are listed as part of the CRP regulon. Future work describing
the intricate regulatory pathways between respiratory and
fermentative growth and the impact of growth condition
on virulence factor production is definitely warranted to
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better propose efficient strategies to combat V. cholerae
infection. 
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